Rhodopsin Trafficking and Retinal Degenerations
视紫红质贩运和视网膜变性
基本信息
- 批准号:8324689
- 负责人:
- 金额:$ 34.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-30 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffinityAnimalsBindingBiogenesisC-terminalCarrier ProteinsCellsCellular biologyChimeric ProteinsCo-ImmunoprecipitationsCultured CellsDefectDevelopmentDiseaseDominant-Negative MutationEpitopesFutureGenesGoalsGreen Fluorescent ProteinsHomozygoteHumanImageImmunoblottingIn VitroInborn Genetic DiseasesKnock-in MouseLeadLightLocationMass Spectrum AnalysisMediatingMediator of activation proteinMembraneMembrane ProteinsModelingMolecularMonitorMovementMusMutationNerve DegenerationNeurodegenerative DisordersNeuronsNeurosciencesPathway interactionsPhotoreceptorsProcessProtein BindingProteinsRegulatory ElementResearchRetinalRetinal DegenerationRetinitis PigmentosaRhodopsinRod Outer SegmentsRoleSignal TransductionSignaling ProteinSorting - Cell MovementStagingStructureTestingTimeWorkabstractingin vivoinsightmembrane assemblymutantphotoactivationphotoreceptor discpolarized cellprotein protein interactionreceptorresearch studyretinal rodsrhotooltrafficking
项目摘要
Project Summary/Abstract
One of the most fundamental problems in molecular neuroscience and cell biology is the proper
assembly of signal-transducing membranes including the transport and sorting of protein components.
A major cause of neurodegenerative and other inherited disorders is the improper localization of
receptors and other signaling or transport proteins.
The goal of this study is to identify proteins that interact with rhodopsin during transport and those
involved in the biogenesis of disk membranes in the outer segment of rod cells, and then determine the
molecular mechanisms by which the molecular interactions of rhodopsin with other proteins lead to
formation of healthy photoreceptor disk membranes. This work will further the understanding of the
mechanisms of neurodegenerative disorders caused by improper trafficking of receptors and other
membrane proteins. The focus of the proposed research is to understand protein-protein interactions
that are defective when rhodopsin lacks the proper structure at its carboxy-terminus, as is the case in
several of the most severe forms of autosomal dominant retinitis pigmentosa. We will use powerful
mouse knock-in models that my co-workers and I have developed, as well as new models proposed
herein.
In Aim 1, we will identify proteins that interact with rhodopsin's carboxy-terminus to mediate proper
transport and disk membrane assembly through affinity-capture experiments using retinal extracts from
homozygote rhodopsin mutants with defective carboxyl-termini knock-in animals. In Aim 2, we will
characterize, first in vitro, then in vivo, a mutant rhodopsin, Ter349Glu, containing a carboxyl-terminal
extension that causes one of the most severe forms of rhodopsin-mediated autosomal dominant
retinitis pigmentosa. In Aim 3, we will develop a new tool, human rhodopsin fused to photoactivatable
green fluorescent protein that is followed by a repeat of rhodopsin's carboxyl terminus (rho-paGFP-
1D4). This construct will be used in two distinct ways: first, we will test the hypothesis that an
unobstructed rhodopsin carboxy-terminus is sufficient to form proper outer segments in healthy rods in
knock-in animals. Second, we will study the role of specific protein-protein interactions in rhodopsin
trafficking after photoactivation of GFP, enabling us to track the movement of subpopulations of
rhodopsin in cells for the first time. This sets the stage for in vivo trafficking studies in the future. Project Narrative
The focus of this study is to understand protein-protein interactions that are defective
when the dim light photoreceptor rhodopsin lacks the proper structure at its carboxy-
terminus, as is the case in several of the most severe forms of autosomal dominant
retinitis pigmentosa. We will study the role of rhodopsin in proper rod cell formation and
degeneration, and monitor its trafficking to better understand these processes.
项目概要/摘要
分子神经科学和细胞生物学中最基本的问题之一是正确的
信号转导膜的组装,包括蛋白质成分的运输和分类。
神经退行性疾病和其他遗传性疾病的一个主要原因是神经元定位不当
受体和其他信号或转运蛋白。
本研究的目的是鉴定在运输过程中与视紫红质相互作用的蛋白质以及那些
参与视杆细胞外节盘膜的生物发生,然后确定
视紫红质与其他蛋白质的分子相互作用导致的分子机制
形成健康的感光盘膜。这项工作将进一步加深对
由受体和其他物质的不当运输引起的神经退行性疾病的机制
膜蛋白。拟议研究的重点是了解蛋白质-蛋白质相互作用
当视紫红质在其羧基末端缺乏适当的结构时,它们就会有缺陷,就像在
几种最严重的常染色体显性遗传性色素性视网膜炎。我们将用强大的
我和我的同事开发的小鼠敲入模型,以及提出的新模型
在此处。
在目标 1 中,我们将鉴定与视紫红质羧基末端相互作用以介导适当的蛋白质
使用视网膜提取物通过亲和捕获实验进行运输和盘膜组装
具有缺陷的羧基末端敲入动物的纯合视紫红质突变体。在目标 2 中,我们将
首先在体外,然后在体内表征含有羧基末端的突变视紫红质 Ter349Glu
延伸导致视紫红质介导的常染色体显性遗传的最严重形式之一
视网膜色素变性。在目标 3 中,我们将开发一种新工具,将人类视紫红质与光激活融合
绿色荧光蛋白,后面是视紫红质羧基末端的重复 (rho-paGFP-
1D4)。该构造将以两种不同的方式使用:首先,我们将测试以下假设:
畅通无阻的视紫红质羧基末端足以在健康的视杆细胞中形成适当的外部片段
敲入动物。其次,我们将研究视紫红质中特定蛋白质-蛋白质相互作用的作用
GFP 光激活后的贩运,使我们能够追踪 GFP 亚群的移动
视紫红质首次进入细胞。这为未来体内贩运研究奠定了基础。项目叙述
这项研究的重点是了解有缺陷的蛋白质-蛋白质相互作用
当弱光感光体视紫红质在其羧基处缺乏正确的结构时
终点,就像几种最严重的常染色体显性遗传形式的情况一样
视网膜色素变性。我们将研究视紫红质在适当的视杆细胞形成中的作用和
退化,并监测其贩运以更好地了解这些过程。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
In vitro biochemical assays to monitor rhodopsin function.
- DOI:10.1007/978-1-61779-848-1_11
- 发表时间:2012-01-01
- 期刊:
- 影响因子:0
- 作者:Sammons, Joshua;Gross, Alecia K
- 通讯作者:Gross, Alecia K
Biochemical analysis of a rhodopsin photoactivatable GFP fusion as a model of G-protein coupled receptor transport.
- DOI:10.1016/j.visres.2013.10.008
- 发表时间:2013-12-18
- 期刊:
- 影响因子:1.8
- 作者:Sammons, Joshua D.;Gross, Alecia K.
- 通讯作者:Gross, Alecia K.
Aberrant protein trafficking in retinal degenerations: The initial phase of retinal remodeling.
- DOI:10.1016/j.exer.2015.11.007
- 发表时间:2016-09
- 期刊:
- 影响因子:3.4
- 作者:Bales KL;Gross AK
- 通讯作者:Gross AK
An activated unfolded protein response promotes retinal degeneration and triggers an inflammatory response in the mouse retina.
- DOI:10.1038/cddis.2014.539
- 发表时间:2014-12-18
- 期刊:
- 影响因子:9
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alecia K Gross其他文献
Alecia K Gross的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alecia K Gross', 18)}}的其他基金
Photoreceptor Disk Formation and Retinal Degenerations
感光盘形成和视网膜变性
- 批准号:
10513271 - 财政年份:2021
- 资助金额:
$ 34.8万 - 项目类别:
Photoreceptor Disk Formation and Retinal Degenerations
感光盘形成和视网膜变性
- 批准号:
10630364 - 财政年份:2020
- 资助金额:
$ 34.8万 - 项目类别:
Photoreceptor Disk Formation and Retinal Degenerations
感光盘形成和视网膜变性
- 批准号:
10723124 - 财政年份:2020
- 资助金额:
$ 34.8万 - 项目类别:
Photoreceptor Disk Formation and Retinal Degenerations
感光盘形成和视网膜变性
- 批准号:
10530730 - 财政年份:2020
- 资助金额:
$ 34.8万 - 项目类别:
Photoreceptor Disk Formation and Retinal Degenerations
感光盘形成和视网膜变性
- 批准号:
10415996 - 财政年份:2020
- 资助金额:
$ 34.8万 - 项目类别:
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
面向免疫疗法标志物识别的基于多特征融合的肽与MHC亲和力预测研究
- 批准号:62302277
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向多场景应用的药物-靶标结合亲和力预测研究
- 批准号:62371403
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 34.8万 - 项目类别:
Development of Antisense Oligonucleotides to Regulate Gamma' Fibrinogen Levels
开发反义寡核苷酸来调节γ纤维蛋白原水平
- 批准号:
10759950 - 财政年份:2023
- 资助金额:
$ 34.8万 - 项目类别:
Broadly neutralizing SARS-CoV-2 peptidic knobs
广泛中和 SARS-CoV-2 肽旋钮
- 批准号:
10735902 - 财政年份:2023
- 资助金额:
$ 34.8万 - 项目类别:
Prefrontal impairment with stress- NE receptor subtype mechanisms.
与压力-NE受体亚型机制有关的前额损伤。
- 批准号:
10655735 - 财政年份:2023
- 资助金额:
$ 34.8万 - 项目类别:
Bispecific immunotherapeutic delivery system for lung diseases
用于肺部疾病的双特异性免疫治疗递送系统
- 批准号:
10720773 - 财政年份:2023
- 资助金额:
$ 34.8万 - 项目类别: